# Redbook 2000: IV.B.3. Pathology Considerations in Toxicity Studies - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/redbook-2000-ivb3-pathology-considerations-in-toxicity-studies/6e01b43c-99b6-4d36-9216-addf9b4e51c0

> FDA guidance document: Redbook 2000: IV.B.3. Pathology Considerations in Toxicity Studies. Issue date: July 01, 2000. Get complete insights and analysis.

---

## Details

- Title: Redbook 2000: IV.B.3. Pathology Considerations in Toxicity Studies
- Communication Type: Guidance Document
- Product Type: Food & Beverages
- Office Name: Human Foods Program
- Issue Date: 2000-07-01

## Related Documents

- [Redbook 2000: IV.C.9.b. Guidelines for Developmental Toxicity Studies](https://www.keypedia.com/guidances/guidance-document/redbook-2000-ivc9b-guidelines-for-developmental-toxicity-studies/e0382360-a844-44f6-8f55-d785bc23a557)
- [Redbook 2000: IV.C.10. Neurotoxicity Studies](https://www.keypedia.com/guidances/guidance-document/redbook-2000-ivc10-neurotoxicity-studies/3b4034b9-5fdc-4a29-99c6-88d23eda5e4d)
- [Redbook 2000: IV.B.4. Statistical Considerations in Toxicity Studies](https://www.keypedia.com/guidances/guidance-document/redbook-2000-ivb4-statistical-considerations-in-toxicity-studies/4021481b-262f-490b-9ef8-e40d88e7249c)